文献速递创伤与烧伤复苏、休克与脓毒症

开放与血管内手术技术处理创伤性血管损伤:美国创伤外科协会PROOVIT登记研究综述

Use of open and endovascular surgical techniques to manage vascular injuries in the trauma setting: A review of the American Association for the Surgery of Trauma PROspective Observational Vascular Injury Trial registry.
PubMed 文献 · J Trauma Acute Care Surg · 2018-01-01
一句话结论PROOVIT登记显示,血管内技术最常用于严重钝性多发伤合并非可压迫性躯干出血,与开放手术相比输血更少、院内死亡率更低但住院更长。

该研究回顾了2013年3月至2016年12月美国创伤外科协会PROOVIT登记数据库中22家机构共1143例命名动脉损伤(除外前臂和小腿)的创伤患者,重点分析非可压迫性横断、部分横断或限流性缺损损伤。血管内技术在下肢创伤中使用最少,在钝性多区域损伤中使用最多;任何区域的穿透伤优先采用开放手术(74%,n=341/459)。血管内治疗最常见指征为钝性非可压迫性躯干损伤,这类患者损伤严重度评分更高、住院时间更长,但所需浓缩红细胞更少,且院内死亡率低于开放手术组。多因素分析显示,入院低血红蛋白浓度和腹部损伤是死亡的独立预测因素。

要点

  • 血管内技术最常用于严重钝性创伤合并非可压迫性躯干出血,该组患者损伤严重度评分更高、住院更长,但浓缩红细胞需求更少、院内死亡率更低。
  • 任何区域的穿透伤优先采用开放手术,占穿透伤的74%(n=341/459)。
  • 血管内技术在下肢创伤中使用最少。
  • 多因素分析显示入院低血红蛋白浓度和腹部损伤是死亡的独立预测因素。

适用人群与场景

  • 2013年3月至2016年12月期间入选PROOVIT登记的创伤患者,所有命名动脉损伤者,但除外前臂和小腿动脉损伤。
  • 本综述重点分析非可压迫性横断、部分横断或限流性缺损损伤的患者。
  • 动脉按解剖区域分组,并分为可压迫与不可压迫区域进行分析。

研究设计与关键结果

  • 研究类型为登记数据库综述,纳入22家机构共1143例患者,中位年龄32岁(四分位距23-48),男性76%(n=871)。
  • 损伤机制:钝性49%(n=561),穿透性41%(n=464),混合病因1.8%(n=21);穿透伤中枪伤占73%(n=341)。
  • 血管内技术在下肢创伤中使用最少,在钝性多区域损伤中使用最多;任何区域穿透伤优先开放手术(74%,n=341/459)。
  • 血管内治疗最常见指征为钝性非可压迫性躯干损伤;该组患者损伤严重度评分更高、住院时间更长,但所需浓缩红细胞更少,院内死亡率低于开放手术组。
  • 多因素分析显示,入院低血红蛋白浓度和腹部损伤是死亡的独立预测因素。

证据类型、等级与局限

  • 证据类型:登记数据库综述(PROOVIT登记),证据等级为治疗/临床管理III级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,PROOVIT登记数据显示血管内治疗在严重钝性创伤合并非可压迫性躯干出血中应用率高,与输血需求减少和生存改善相关,但住院时间更长。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Vascular trauma data have been submitted to the American Association for the Surgery of Trauma PROspective Observational Vascular Injury Trial (PROOVIT) database since 2013. We present data to describe current use of endovascular surgery in vascular trauma.

METHODS: Registry data from March 2013 to December 2016 were reviewed. All trauma patients who had an injury to a named artery, except the forearm and lower leg, were included. Arteries were grouped into anatomic regions and by compressible and noncompressible region for analysis. This review focused on patients with noncompressible transection, partial transection, or flow-limiting defect injuries. Bivariate and multivariate analyses were used to assess the relationships between study variables.

RESULTS: One thousand one hundred forty-three patients from 22 institutions were included. Median age was 32 years (interquartile range, 23-48) and 76% (n = 871) were male. Mechanisms of injury were 49% (n = 561) blunt, 41% (n = 464) penetrating, and 1.8% (n = 21) of mixed aetiology. Gunshot wounds accounted for 73% (n = 341) of all penetrating injuries. Endovascular techniques were used least often in limb trauma and most commonly in patients with blunt injuries to more than one region. Penetrating wounds to any region were preferentially treated with open surgery (74%, n = 341/459). The most common indication for endovascular treatment was blunt noncompressible torso injuries. These patients had higher Injury Severity Scores and longer associated hospital stays, but required less packed red blood cells, and had lower in hospital mortality than those treated with open surgery. On multivariate analysis, admission low hemoglobin concentration and abdominal injury were independent predictors of mortality.

CONCLUSION: Our review of PROOVIT registry data demonstrates a high utilization of endovascular therapy among severely injured blunt trauma patients primarily with noncompressible torso hemorrhage. This is associated with a decreased need for blood transfusion and improved survival despite longer length of stay.

LEVEL OF EVIDENCE: Therapeutic/care management, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Faulconer ER, Branco BC, Loja MN, et al. Use of open and endovascular surgical techniques to manage vascular injuries in the trauma setting: A review of the American Association for the Surgery of Trauma PROspective Observational Vascular Injury Trial registry. J Trauma Acute Care Surg. 2018. PMID: 29462113. doi:10.1097/TA.0000000000001776

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。